Literature DB >> 30763943

Diversity of Nontuberculous Mycobacteria in Kuwait: Rapid Identification and Differentiation of Mycobacterium Species by Multiplex PCR, INNO-LiPA Mycobacteria v2 Assay and PCR Sequencing of rDNA.

Suhail Ahmad1, Eiman Mokaddas2.   

Abstract

OBJECTIVE: Nontuberculous mycobacteria (NTM) often cause disease that is clinically indistinguishable from tuberculosis. Specific identification is important as treatment varies according to Mycobacterium species causing the infection. This study used multiplex PCR (mPCR) assay for rapid differentiation of mycobacterial growth indicator tube 960 system (MGIT) cultures as Mycobacterium tuberculosis (MTB) or NTM together with INNO LiPA Mycobacteria v2 assay (LiPA) and/or PCR sequencing of rDNA for species-specific identification of selected MTB and all NTM isolates in Kuwait.
MATERIALS AND METHODS: DNA was extracted from MGIT cultures (n = 1,033) grown from 664 pulmonary and 369 extrapulmonary specimens from 1,033 suspected tuberculosis patients. mPCR was performed to differentiate MTB from NTM. LiPA was performed and results were interpreted according to kit instructions. rDNA was amplified and sequenced by using panmycobacterial primers.
RESULTS: mPCR identified 979 isolates as MTB, 53 as NTM and 1 isolate as mixed culture. LiPA and/or PCR sequencing confirmed 112 of 979 selected isolates as MTB. Mixed culture contained M. tuberculosis and M. fortuitum. LiPA yielded 12 patterns and identified 10 species/species complexes among 47 NTM, M. kansasii + M. scrofulaceum in one culture and 5 isolates only at genus level. PCR sequencing yielded more specific identification for 22 isolates at the species/subspecies level.
CONCLUSIONS: mPCR rapidly differentiated MTB from NTM. LiPA identified 44 of 52 NTM isolates at the species/species complex level and 2 mixed cultures. PCR sequencing yielded more specific identification at the species/subspecies level. Rapid differentiation as MTB or NTM by mPCR, followed by species-specific NTM identification by LiPA/PCR sequencing is suitable for the proper management of mycobacterial infections in Kuwait.
© 2019 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  INNO LiPA Mycobacteria v2 assay; Multiplex PCR; Mycobacterial identification; NTM species; PCR sequencing of 16S-23S rDNA

Mesh:

Substances:

Year:  2019        PMID: 30763943      PMCID: PMC6597937          DOI: 10.1159/000498910

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  30 in total

Review 1.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

2.  Accurate differentiation of Mycobacterium chimaera from Mycobacterium intracellulare by MALDI-TOF MS analysis.

Authors:  Arthur B Pranada; Ellen Witt; Michael Bienia; Markus Kostrzewa; Markus Timke
Journal:  J Med Microbiol       Date:  2017-05-15       Impact factor: 2.472

3.  Rapid differentiation of mycobacteria by simplex real-time PCR with melting temperature calling analysis.

Authors:  L Lin; X Yin; Q Wang
Journal:  J Appl Microbiol       Date:  2015-08-02       Impact factor: 3.772

4.  Discrimination of Mycobacterium abscessus subsp. massiliense from Mycobacterium abscessus subsp. abscessus in clinical isolates by multiplex PCR.

Authors:  Kazue Nakanaga; Tsuyoshi Sekizuka; Hanako Fukano; Yumi Sakakibara; Fumihiko Takeuchi; Shinpei Wada; Norihisa Ishii; Masahiko Makino; Makoto Kuroda; Yoshihiko Hoshino
Journal:  J Clin Microbiol       Date:  2013-11-06       Impact factor: 5.948

5.  Species spectrum of nontuberculous mycobacteria isolated from clinical specimens in Kuwait.

Authors:  Eiman Mokaddas; Suhail Ahmad
Journal:  Curr Microbiol       Date:  2008-01-30       Impact factor: 2.188

6.  Development and evaluation of a multiplex PCR for rapid detection and differentiation of Mycobacterium tuberculosis complex members from non-tuberculous mycobacteria.

Authors:  Eiman Mokaddas; Suhail Ahmad
Journal:  Jpn J Infect Dis       Date:  2007-05       Impact factor: 1.362

Review 7.  New approaches in the diagnosis and treatment of latent tuberculosis infection.

Authors:  Suhail Ahmad
Journal:  Respir Res       Date:  2010-12-03

8.  Emergence of Rare Species of Nontuberculous Mycobacteria as Potential Pathogens in Saudi Arabian Clinical Setting.

Authors:  Bright Varghese; Mushira Enani; Mohammed Shoukri; Sahar AlThawadi; Sameera AlJohani; Sahal Al-Hajoj
Journal:  PLoS Negl Trop Dis       Date:  2017-01-11

9.  Clinical relevance of nontuberculous Mycobacteria, Oman.

Authors:  Sara H Al-Mahruqi; Jakko van-Ingen; Suleiman Al-Busaidy; Martin J Boeree; Samiya Al-Zadjali; Arti Patel; P N Richard-Dekhuijzen; Dick van-Soolingen
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

10.  Mycobacterium abscessus Complex Infections: A Retrospective Cohort Study.

Authors:  Maroun Sfeir; Marissa Walsh; Rossana Rosa; Laura Aragon; Sze Yan Liu; Timothy Cleary; Marylee Worley; Corey Frederick; Lilian M Abbo
Journal:  Open Forum Infect Dis       Date:  2018-02-09       Impact factor: 3.835

View more
  2 in total

1.  First insights into the phylogenetic diversity of Mycobacterium tuberculosis in Kuwait and evaluation of REBA MTB-MDR assay for rapid detection of MDR-TB.

Authors:  Noura M Al-Mutairi; Suhail Ahmad; Eiman Mokaddas; Sahal Al-Hajoj
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

2.  Performance Comparison of GeneXpert MTB/RIF and ProbeTec ET Tests for Rapid Molecular Diagnosis of Extrapulmonary Tuberculosis in a Low TB/MDR-TB Incidence Country.

Authors:  Eiman Mokaddas; Suhail Ahmad; Hanaa Eldeen
Journal:  Med Princ Pract       Date:  2021-02-16       Impact factor: 1.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.